Eli Lilly drug shows significant risk reduction for diabetes and cardiovascular disease
Eli Lilly's Foundayo 17.2 Mg demonstrated a 57% reduction in diabetes risk and an 18% reduction in cardiovascular risk compared to placebo.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.